Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
Currents in Pharmacy Teaching & Learning|September 14, 2022
Effectiveness of educational program on systematic and extensive palliative care in cancer patients for pharmacistsMayako Uchida, Masahiro Yamada, Masao Hada, et al.
Journal of Pharmaceutical Health Care and Sciences|October 15, 2019
Evaluation of adverse events focusing on infection associated with infliximab originator and biosimilar using a spontaneous reporting system databaseIku Niinomi, Keiko Hosohata, Yasuhiro Mori, et al.
Current Therapeutic Research, Clinical and Experimental|July 19, 2026
Association Between Perioperative Daprodustat Use and Early Posttransplant Graft Function in Living Donor Kidney Transplantation: A Propensity Score-Matched Retrospective StudyTomohiro Shigematsu, Soichiro Tajima, Hiroshi Noguchi, et al.
In Vivo (Athens, Greece)|December 31, 2024
Evaluation of Times-to-onset and Outcomes of Lung Adverse Events Associated With Sorafenib Using JADERYuko Kanbayashi, Rio Tomii, Naru Yamamoto, et al.
Currents in Pharmacy Teaching & Learning|March 15, 2021
Evaluation of changes in pharmacist behaviors following a systematic education program on palliative care in cancerMasahiro Yamada, Mayako Uchida, Masao Hada, et al.
Biological & Pharmaceutical Bulletin|July 2, 2019
Analyses of Respiratory Depression Associated with Opioids in Cancer Patients Based on the Japanese Adverse Drug Event Report DatabaseHideki Sugawara, Mayako Uchida, Shinya Suzuki, et al.
Journal of Clinical Pharmacology|August 6, 2025
Disproportionality Analysis of Intravitreal Ranibizumab, Aflibercept, and Brolucizumab for Cardiovascular and Cerebrovascular EventsKeisuke Nosaka, Shuji Nagano, Masaki Fujiwara, et al.
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|January 21, 2024
Opioid-Related Respiratory Depression in Non-Cancer Patients, as Reported in the Japanese Adverse Drug Event Report DatabaseHideki Sugawara, Mayako Uchida, Shinya Suzuki, et al.
Pageof 11